Contact
Please use this form to send email to PR contact of this press release:
ASLAN Pharmaceuticals Submits Clinical Trial Authorisation Application for First in Man Studies for ASLAN004
TO:
Please use this form to send email to PR contact of this press release:
ASLAN Pharmaceuticals Submits Clinical Trial Authorisation Application for First in Man Studies for ASLAN004
TO: